IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Phase 2 biotech developing therapies for the treatment of fibrosis.
Industry: Health Care
Latest Trade: $37.06 +3.97 (+12.0%)
First Day Return: +33.1%
Return from IPO: +106.8%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 05/11/2020 |
Offer Price | $16.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 9.0 |
Deal Size ($mm) | $144 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 06/02/2020 |
Offer Price | $16.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 9.0 |
Deal Size ($mm) | $144 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
more |
Company Data | |
---|---|
Headquarters | South San Francisco, CA |
Founded | 2016 |
Employees | 62 |
Website www.plianttrx.com |